Patent ID: 11918817
Assignee: PACESETTER, INC.
Field: Medical technology (Instruments)
Classification: CPC A  H | IPC A  H

Claim 16:
17. A method for providing an implantable leadless pacemaker (LP) with a remote follow-up capability whereby the LP can provide diagnostic information to an external device that is incapable of programming the LP, wherein the LP includes two or more implantable electrodes used to output both pacing pulses and conductive communication pulses, the method comprising:
the LP monitoring for a presence of one or more notification conditions associated with the LP and/or associated with a patient within which the LP is implanted;
the LP periodically outputting an advertisement sequence of pulses, using at least two of the two or more implantable electrodes of the LP, irrespective of whether the LP recognizes the presence of at least one said notification condition;
the LP recognizing the presence of at least one said notification condition, and based thereon, the LP also outputting a notification sequence of pulses, using at least two of the two or more implantable electrodes of the LP, within one or more notification transmission windows following the outputting of the advertisement sequence of pulses, the notification sequence of pulses encoded with diagnostic information associated with the LP and/or associated with the patient within which the LP is implanted;
wherein the advertisement sequence of pulses and the notification sequence of pulses and/or information encoded therein are capable of being received by an external device that includes or is communicatively coupled to two or more external electrodes used to receive conductive communication pulses from the LP or by another implantable medical device (IMD) that includes two or more electrodes used to receive conductive communication pulses from the LP;
wherein the one or more notification conditions that the LP monitors for includes at least one notification condition associated with the LP and/or at least one notification condition associated with the patient within which the LP is implanted;
wherein the at least one notification condition associated with the LP comprises one or more of a recommended replacement time (RRT) condition, a device reset condition, an end of service (EOS) condition, a high current condition, a memory region full condition, a memory corruption condition, or a poor conductive communication condition; and
wherein the at least one notification condition associated with the patient comprises one or more of an arrhythmia detection, a non-cardiac physiological condition detection, an increased pacing burden detection, an automatic mode switching (AMS) detection, a pacemaker mediated tachycardia (PMT) detection, or a premature ventricular contraction (PVC) detection.